Camarillo, CA, United States of America

Christopher Francis Toombs

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2000-2011

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Christopher Francis Toombs: Innovator in Protein Compositions

Introduction

Christopher Francis Toombs is a notable inventor based in Camarillo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of protein compositions that have therapeutic applications. With a total of 10 patents, Toombs has established himself as a key figure in the innovation of medical treatments.

Latest Patents

Among his latest patents, Toombs has developed compositions and methods related to OB fusion proteins. One of his inventions focuses on Fc-OB fusion protein compositions, which involve a genetic or chemical fusion of the Fc immunoglobulin region with the N-terminal portion of the OB protein. This innovation has potential applications in various therapeutic areas. Another significant patent addresses methods for increasing lean tissue mass using OB protein compositions. This patent describes DNA sequences that encode fusion proteins, which can be utilized to enhance insulin sensitivity, regulate serum glucose levels, and improve overall body strength.

Career Highlights

Toombs has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Amylin Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative protein-based therapies.

Collaborations

Throughout his career, Toombs has collaborated with notable professionals in the field, including Michael B Mann and Mary Ann Pelleymounter. These collaborations have likely enriched his research and development efforts.

Conclusion

Christopher Francis Toombs is a distinguished inventor whose work in protein compositions has the potential to impact therapeutic practices significantly. His innovative patents and collaborations reflect his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…